Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?

American Journal of Bioethics 20 (4):111-113 (2020)
  Copy   BIBTEX

Abstract

Volume 20, Issue 4, May 2020, Page 111-113.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 94,439

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Ethical Training Can Turn an “Ought” to a “Can”.Ira Bedzow & Matthew Wynia - 2020 - American Journal of Bioethics 20 (4):73-75.

Analytics

Added to PP
2020-03-25

Downloads
21 (#742,929)

6 months
12 (#312,707)

Historical graph of downloads
How can I increase my downloads?